Influence of seasonal and operating conditions on the rejection of pharmaceutical active compounds by RO and NF membranes

Desalination

Volumn 277, Issue 1-3, 2011, Pages 250-256

  Gur Reznik, Shirra ^a   Koren Menashe, Ifat ^a   Heller Grossman, Lilly ^a   Rufel, Ofir ^a   Dosoretz, Carlos G ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Desalination; Effluent purification; Iodinated contrast media; Nanofiltration; Pharmaceuticals; Reverse osmosis

Indexed keywords

BIOLOGICAL TRANSFORMATION; CARBAMAZEPINE; DIATRIZOATE; EFFLUENT ORGANIC MATTER; HIGH STABILITY; HIGHLY-CORRELATED; IODINATED CONTRAST MEDIA; MATRIX; MEMBRANE BIOREACTOR; NF MEMBRANES; OPERATING CONDITION; PHARMACEUTICAL ACTIVE COMPOUNDS; REJECTION EFFICIENCY; SEASONAL CHANGES; TRANSMEMBRANE PRESSURES; ULTRA-PURE WATER; WASTEWATER TREATMENT PLANTS;

AMIDES; BIOLOGICAL WATER TREATMENT; BIOREACTORS; CONTRAST MEDIA; DESALINATION; DRUG PRODUCTS; EFFLUENTS; HYDROPHOBICITY; IONIC STRENGTH; NANOFILTRATION; OSMOSIS; PRESSURE EFFECTS; REVERSE OSMOSIS; WASTEWATER; WASTEWATER TREATMENT; WATER FILTRATION; WATER TREATMENT PLANTS;

OSMOSIS MEMBRANES;

BIOREACTOR; DESALINATION; DRUG; EFFLUENT; FILTRATION; HYDROPHOBICITY; MEMBRANE; ORGANIC MATTER; OSMOSIS;

EID: 79960175948     PISSN: 00119164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.desal.2011.04.029     Document Type: Article

References (41)

1. Ternes T.A. The occurrence of micropollutants in the aquatic environment: a new challenge for water management. Water Sci. Technol. 2007, 55:327-332.
2. Ternes T.A., Joss A. Human Pharmaceuticals, Hormones and Fragrances: the Challenge of Micropollutants in Urban Water Management 2006, IWA Publishing, London.
3. Oleksy-Frenzel J., Wischnack S., Jekel M. Application of ion-chromatography for the determination of the organic-group parameters AOCl, AOBr and AOI in water. J. Anal. Chem. 2000, 366:89-94.
4. Miao X.-S., Metcalfe D.C. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal. Chem. 2003, 75:3731-3738.
5. Pérez S., Barceló D. Fate and occurrence of X-ray contrast media in the environment. Anal. Bioanal. Chem. 2007, 387:1235-1246.
6. Wenzel A., Müller J., Ternes J. Study on endocrine disrupters in drinking water. Final Report, Institute for Water Research and Water Technology (JOGU-ESWE) 2003.
7. Kimura K., Amy G., Drewes J.E., Watanabe Y. Adsorption of hydrophobic compounds onto NF/RO membranes: an artifact on overestimation of rejection. J. Mem. Sci. 2003, 221:89-101.
8. Nghiem D.L., Schäfer A.I., Elimelech M. Removal of natural hormones by nanofiltration membranes: measurement, modeling, and mechanisms. Environ. Sci. Technol. 2004, 38:1888-1896.
9. Salveson A.T., Requa D.A., Whitley R.D., Tchobanoglous G. Potable versus reclaimed water quality, regulatory issues, emerging concerns. Annual Conference Water Environment Federation 2000, WEFTEC, Anaheim, CA.
10. Bellona C., Drewes J.E., Xu P., Amy G. Factors affecting the rejection of organic solutes during NF-RO treatment - a literature review. Water Res. 2004, 38:2795-2809.
11. Heijman S.G.J., Verliefde A.R.D., Cornelissen E.R., Amy G., van Dijk J.C. Influence of natural organic matter (NOM) fouling on the removal of pharmaceuticals by nanofiltration and activated carbon filtration. Water Sci. Technol. 2007, 7:17-23.
12. Kimura K., Toshima S., Amy G., Watanabe Y. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Mem. Sci. 2004, 245:71-78.
13. Nghiem D.L., Schäfer A.I., Elimelech M. Pharmaceutical retention mechanisms by nanofiltration membranes. Environ. Sci. Technol. 2005, 39:7698-7705.
14. Verliefde A.R.D., Cornelissen E.R., Heijmana S.G.J., Petrinic I., Luxbacherd T., Amy G.L., Van der Bruggen B., Dijka J.C.V. Influence of membrane fouling by (pretreated) surface water on rejection of pharmaceutically active compounds (PhACs) by nanofiltration membranes. J. Mem. Sci. 2009, 330:90-103.
15. KošutiŽ K., Dolar D., Ašperger D., Kunst B. Removal of antibiotics from a model wastewater by RO/NF membranes. Sep. Purif. Technol. 2007, 53:244-249.
16. Yoon Y., Westerhoff P., Snyder S.A., Wert E.C. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Mem. Sci. 2006, 270:88-100.
17. Comerton M.A., Andrews C.R., Bagley M.D., Hao C. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties. J. Mem. Sci. 2008, 313:323-335.
18. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
19. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
20. Oliver A., Lester J.N., Voulvoulis N. Pharmaceuticals: a threat to drinking waterŽ. Trends Biotechnol. 2005, 23:163-167.
21. Snyder S.A., Adham S., Redding A.M., Cannon F.S., DeCarolis J., Oppenheimer J., Wert E.C., Yoon Y. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202:156-181.
22. Drewes J.E., Oedekoven M., Xu P., Kim T.-U., Amy G. Rejection of wastewater-derived micropollutants in high-pressure membrane applications leading to indirect potable reuse. Environ. Prog. 2005, 24:400-409.
23. Kimura K., Iwase T., Kita S., Watanabe Y. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes. Water Res. 2009, 43:3751-3758.
24. Park G.Y., Lee J.H., Kim I.S., Cho J. Pharmaceutical rejection by membranes for wastewater reclamation and reuse. Water Sci. Technol. 2004, 50:239-244.
25. Katz I., Dosoretz C.G. Desalination of domestic wastewater effluents: phosphate removal as pretreatment. Desalination 2008, 222:230-242.
26. Gur-Reznik S., Katz I., Dosoretz C.G. Removal of dissolved organic matter by granular-activated carbon adsorption as a pretreatment to reverse osmosis of membrane bioreactor effluents. Water Res. 2008, 42:1595-1605.
27. Even-Ezra I., Beliavski M., Tarre S., Dosoretz C., Green M. Chemical versus biological pretreatment for membrane filtration of domestic wastewater. Desalination 2011, 272:85-89.
28. Tchobanoglous G., Burton F.L., Stensel H.D. Wastewater Engineering: Treatment and Reuse 2003, Metcalf and Eddy Inc, McGraw-Hill, New York. 4th ed.
29. Eaton A.D., Clesceri L.S., Greenberg A.E. Standard Methods for the Examination of Water and Wastewater 1995, American Public Health Association, Washington, DC. 19th ed.
30. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 2003, 75:6285-6274.
31. Hirsch R., Ternes T.A., Lindart A., Heberer K., Wilken R.-D. A sensitive method for the determination of iodine containing diagnostic agents in aqueous matrices using LC-electrospray-tandem-MS detection. J. Anal. Chem. 2000, 366:835-841.
32. Comerton M.A., Andrews C.R., Bagley M.D., Yang P. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds. J. Mem. Sci. 2007, 303:267-277.
33. Beausse J. Selected drugs in solid matrices: a review of environmental occurrence, determination, and properties of principal substances. European Union Scientific Support to Policies Project Horizontal, Report DS26-Pharmaceuticals 2004, Available, Anjou Recherché, Veolia Water, Saint Maurice, France. http://www.ecn.nl/docs/society/horizontal/hor_desk_26_pharmaceuticals.pdf.
34. KošutiŽ K., Kunst B. Removal of organics from aqueous solutions by commercial RO and NF membranes of characterized porosities. Desalination 2002, 142:47-56.
35. Boussu K., Zhang Y., Cocquyt J., Van der Meeren P., Volodin A., Van Haesendonck C., Martens J.A., Van der Bruggen B. Characterization of polymeric nanofiltration membranes for systematic analysis of membrane performance. J. Mem. Sci. 2006, 278:418-427.
36. Kim T.-U., Amy G., Drewes J.E. Rejection of trace organic compounds by high-pressure membranes. Water Sci. Technol. 2005, 6-7:335-344.
37. Schäfer A.I., Nghiem D.L., Waite T.D. Removal of the natural hormone estrone from aqueous solutions using nanofiltration and reverse osmosis. Environ. Sci. Technol. 2003, 37:182-188.
38. Elmitwalli T.A., Zeeman G., Lettinga G. Anaerobic treatment of domestic sewage at low temperature. Water Sci. Technol. 2001, 44:33-40.
39. Lew B., Tarre S., Beliavski M., Dosoretz C.G., Green M. Anaerobic membrane bioreactor (AnMBR) for domestic wastewater treatment. Desalination 2009, 243:251-257.
40. G. Peleg, Integrating suspended carriers in a membrane biological reactor. Master Thesis, Technion-Israel Institue of Technology, Haifa, IL, 2010.
41. Boussahel R., Bouland S., Moussaoui K.M., Montiel A. Removal of pesticide residues in water using the nanofiltration process. Desalination 2000, 132:205-209.